Collectively, these studies support the contribution of ANXA2 to promoting the proliferation of glioma cells, and the overexpression of ANXA2 was sufficient to further increase the proliferation of glioma cells, which already expressed high levels of exogenous ANXA2. Here, ANXA2 is linked to central nervous system cancer.